LMR Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-137,117
| Closed | -$592K | – | 1010 |
|
|
2022
Q4 | $592K | Buy |
137,117
+108,860
| +385% | +$470K | 0.01% | 809 |
|
|
2022
Q3 | $212K | Sell |
28,257
-27,676
| -49% | -$208K | ﹤0.01% | 993 |
|
|
2022
Q2 | $562K | Buy |
+55,933
| New | +$562K | 0.01% | 882 |
|
|
2022
Q1 | – | Sell |
-85,593
| Closed | -$1.96M | – | 1211 |
|
|
2021
Q4 | $1.96M | Sell |
85,593
-271,117
| -76% | -$6.2M | 0.02% | 478 |
|
|
2021
Q3 | $7.89M | Buy |
+356,710
| New | +$7.89M | 0.09% | 182 |
|
|
2021
Q1 | – | Sell |
-63,633
| Closed | -$880K | – | 951 |
|
|
2020
Q4 | $880K | Hold |
63,633
| – | – | 0.01% | 297 |
|
|
2020
Q3 | $937K | Hold |
63,633
| – | – | 0.02% | 223 |
|
|
2020
Q2 | $1.03M | Hold |
63,633
| – | – | 0.03% | 355 |
|
|
2020
Q1 | $935K | Buy |
+63,633
| New | +$935K | 0.04% | 135 |
|